What is CUSIP 126650100?

CUSIP 126650100 is the security identifier used in SEC filing datasets for CVS - CVS HEALTH Corp - Common Stock.

Who owns CVS - CVS HEALTH Corp - Common Stock based on 13F filings?

1838 institutions reported positions in CVS - CVS HEALTH Corp - Common Stock as of Q1 2026. Open the latest holders period and ownership history tables on this page for position-level details.

Security Snapshot

CVS HEALTH Corp - Common Stock (CVS) Institutional Ownership

CUSIP: 126650100

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

1,838

Shares (Excl. Options)

1,098,950,292

Price

$71.82

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Type / Class: Equity / Common Stock
Symbol: CVS on NYSE
Shares outstanding: 1,272,949,774
Price per share: $77.94
All holders as of 31 Mar 2026: Q1 2026
Total 13F shares: 1,098,950,292
Total reported value: $78,884,606,028
% of total 13F portfolios: 0.04%
Share change: -29,365,559
Value change: -$2,351,998,252
Number of holders: 1,838
Price from insider filings: $77.94

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Key facts

CVS - CVS HEALTH Corp - Common Stock is tracked under CUSIP 126650100.
1838 institutions reported positions in Q1 2026.
3 significant owners is listed from Schedule 13D/13G reporting.

Change

Holder count moved from 1,933 to 1,838 between Q4 2025 and Q1 2026.
Reported value moved from $89,793,347,758 to $78,884,606,028.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 1838 institutions filings for Q1 2026.

Open SEC Evidence

Security key

126650100

Latest holder period

Q1 2026

13F holders

1,838

13D/G owners

CIK / CUSIP context first

Open Q1 2026 holders CVS full holder history CVS HEALTH Corp SEC filings CVS HEALTH Corp company facts CVS HEALTH Corp insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 126650100:

Q1 2026 (1838 holders) Q4 2025 (1933 holders) Q3 2025 (1822 holders) Q2 2025 (1740 holders) Q1 2025 (1731 holders) Q4 2024 (1641 holders) Q3 2024 (1823 holders) Q2 2024 (1883 holders) Q1 2024 (2137 holders) Q4 2023 (2241 holders)

Significant Owners of CVS HEALTH Corp - Common Stock (CVS) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	8.3%	+17%	$7,263,082,720	+$1,108,806,594	105,292,588	+18%	BlackRock, Inc.	30 Jun 2025
VANGUARD CAPITAL MANAGEMENT LLC	7.5%		$6,865,886,281		95,598,528		Vanguard Capital Management	31 Mar 2026
Capital World Investors	5.5%		$4,534,372,461		68,785,990		Capital World Investors	31 Mar 2025

As of 31 Mar 2026, 1,838 institutional investors reported holding 1,098,950,292 shares of CVS HEALTH Corp - Common Stock (CVS). This represents 86% of the company’s total 1,272,949,774 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CVS HEALTH Corp - Common Stock (CVS) together control 59% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution	Ownership %	Shares Held	Share Change %	Portfolio %	Holdings Value
BlackRock, Inc.	9.9%	125,919,853	+4.1%	0.16%	$9,043,563,867
VANGUARD CAPITAL MANAGEMENT LLC	6.5%	82,650,076	0%	0.15%	$5,935,928,458
Capital World Investors	6.1%	77,248,642	+14%	0.76%	$5,547,533,163
STATE STREET CORP	4.7%	59,322,181	-1.4%	0.15%	$4,260,519,039
Dodge & Cox	4.1%	51,780,116	-17%	2%	$3,718,847,931
FMR LLC	2.5%	31,196,890	-24%	0.12%	$2,240,560,597
JPMORGAN CHASE & CO	2.3%	29,527,125	-5.4%	0.14%	$2,071,032,687
GEODE CAPITAL MANAGEMENT, LLC	2.3%	29,459,042	+1.4%	0.13%	$2,106,670,113
VANGUARD PORTFOLIO MANAGEMENT LLC	2%	25,997,348	0%	0.1%	$1,867,129,533
Invesco Ltd.	2%	25,138,946	+4.7%	0.28%	$1,805,479,134
PRICE T ROWE ASSOCIATES INC /MD/	1.9%	23,783,145	+45%	0.2%	$1,708,106,000
WELLINGTON MANAGEMENT GROUP LLP	1.8%	22,567,732	+22%	0.3%	$1,620,814,512
Capital Research Global Investors	1.6%	20,012,332	+66%	0.22%	$1,437,276,043
MORGAN STANLEY	1.4%	17,825,122	-13%	0.08%	$1,280,200,453
Capital International Investors	1.2%	15,392,222	-44%	0.26%	$1,105,268,805
PZENA INVESTMENT MANAGEMENT LLC	1.1%	13,773,053	-12%	3.2%	$989,180,667
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1.1%	13,674,925	-1.3%	0.15%	$983,193,179
GOLDMAN SACHS GROUP INC	0.99%	12,639,801	+54%	0.12%	$907,790,504
Davis Selected Advisers	0.96%	12,239,666	-4.1%	4%	$879,053,606
NORTHERN TRUST CORP	0.91%	11,641,549	-1.6%	0.11%	$836,096,050
Legal & General Group Plc	0.75%	9,515,723	+2.2%	0.16%	$683,419,227
BANK OF AMERICA CORP /DE/	0.73%	9,351,969	-0.72%	0.05%	$671,658,374
Bank of New York Mellon Corp	0.71%	9,030,161	-0.88%	0.12%	$648,546,169
ROYAL BANK OF CANADA	0.71%	8,984,614	-3%	0.12%	$645,275,000
AMERIPRISE FINANCIAL INC	0.7%	8,954,534	+11%	0.15%	$643,105,461

Institutional Holders of CVS HEALTH Corp - Common Stock (CVS) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2026 Q1	1,098,950,292	$78,884,606,028	-$2,351,998,252	$942,142,620	$1,391,553,316	$71.82	1,838
2025 Q4	1,131,859,006	$89,793,347,758	+$2,670,657,559	$1,357,124,790	$1,594,014,377	$79.36	1,933
2025 Q3	1,092,478,965	$82,350,164,002	+$83,483,263	$1,672,476,759	$2,030,294,959	$75.39	1,822
2025 Q2	1,095,036,129	$75,500,979,208	+$2,280,399,011	$1,535,263,395	$1,806,979,744	$68.98	1,740
2025 Q1	1,064,718,943	$72,113,884,722	+$1,899,695,324	$1,789,222,052	$1,832,788,898	$67.75	1,731
2024 Q4	1,045,708,735	$46,960,631,407	+$1,004,418,915	$1,229,929,877	$1,386,331,596	$44.89	1,641
2024 Q3	1,014,230,760	$63,831,005,436	-$677,262,119	$1,264,344,456	$1,564,692,992	$62.88	1,823
2024 Q2	1,019,162,974	$60,179,918,934	+$1,060,433,822	$995,324,029	$1,265,533,646	$59.06	1,883
2024 Q1	1,001,904,386	$79,807,139,670	-$1,211,883,033	$1,275,636,342	$1,288,808,184	$79.76	2,137
2023 Q4	1,017,403,858	$80,308,314,517	+$1,281,500,162	$1,123,693,269	$1,397,298,124	$78.96	2,241
2023 Q3	999,658,654	$69,795,638,867	+$491,519,511	$1,124,867,486	$1,358,887,635	$69.82	2,096
2023 Q2	994,552,446	$68,776,049,773	-$267,426,998	$945,093,990	$966,981,549	$69.13	2,184
2023 Q1	992,137,419	$73,734,702,204	-$2,430,332,032	$899,944,076	$884,932,637	$74.31	2,238
2022 Q4	1,027,396,077	$95,710,385,316	-$621,742,148	$1,040,950,580	$1,339,071,838	$93.19	2,386
2022 Q3	1,036,131,117	$98,902,299,567	+$583,699,164	$816,993,358	$1,181,406,456	$95.37	2,306
2022 Q2	1,030,185,027	$95,477,208,943	+$457,242,938	$815,718,938	$998,916,806	$92.66	2,292
2022 Q1	1,028,623,372	$104,166,953,205	-$162,318,215	$1,400,102,960	$1,648,769,837	$101.21	2,350
2021 Q4	1,029,470,276	$106,176,980,983	+$782,593,506	$2,370,618,504	$2,295,672,396	$103.16	2,319
2021 Q3	1,017,132,506	$86,349,876,202	+$21,706,246	$1,985,626,742	$1,820,756,604	$84.86	2,053
2021 Q2	1,017,877,459	$84,919,694,336	+$2,053,435,851	$1,689,871,752	$1,647,653,656	$83.44	2,049
2021 Q1	994,144,506	$74,776,454,186	+$4,878,883	$1,436,599,060	$1,282,664,784	$75.23	2,012
2020 Q4	994,787,112	$67,960,797,654	+$33,414,095	$1,284,754,750	$1,821,804,390	$68.30	1,957
2020 Q3	995,752,919	$58,121,993,856	-$1,243,175,311	$1,069,086,520	$1,667,578,080	$58.40	1,799
2020 Q2	1,014,702,612	$65,855,218,901	+$764,515,206	$984,047,323	$1,628,898,189	$64.97	1,845
2020 Q1	1,004,322,951	$59,576,062,642	-$624,760,654	$973,886,000	$1,728,913,000	$59.33	1,791
2019 Q4	1,009,249,813	$74,949,158,076	+$93,638,735	$1,445,369,000	$1,897,880,000	$74.29	1,826
2019 Q3	1,008,703,801	$63,589,810,377	+$683,854,384	$1,216,933,000	$1,319,324,000	$63.07	1,668
2019 Q2	999,569,687	$54,469,262,379	-$125,833,227	$1,328,109,000	$1,044,477,000	$54.49	1,639
2019 Q1	1,015,392,931	$54,753,892,032	-$2,449,316,890	$1,335,318,000	$1,033,878,000	$53.93	1,688
2018 Q4	1,057,172,458	$69,250,872,296	+$12,127,701,193	$649,542,000	$1,053,006,000	$65.52	1,766
2018 Q3	870,738,435	$68,510,150,212	+$1,883,897,727	$944,732,000	$1,181,886,488	$78.72	1,592
2018 Q2	850,535,070	$54,718,204,845	+$271,208,332	$702,978,000	$786,593,000	$64.35	1,560
2018 Q1	855,048,114	$53,133,760,227	+$40,291,614	$549,649,944	$415,797,945	$62.21	1,540
2017 Q4	853,079,066	$61,782,317,199	+$968,323,049	$881,322,500	$581,936,500	$72.50	1,590
2017 Q3	837,796,253	$68,116,730,466	+$56,831,988	$452,785,000	$439,420,000	$81.32	1,521
2017 Q2	837,689,880	$67,390,063,873	-$462,380,881	$507,808,000	$466,042,000	$80.46	1,543
2017 Q1	844,552,702	$66,288,166,171	+$3,453,423,579	$1,072,096,000	$1,082,355,000	$78.50	1,567
2016 Q4	864,216,464	$68,187,625,679	-$1,218,453,807	$671,590,000	$590,356,000	$78.91	1,538
2016 Q3	875,715,124	$77,884,446,974	+$259,099,282	$364,743,000	$458,392,000	$88.99	1,549
2016 Q2	873,506,079	$83,618,862,892	-$2,313,703,183	$294,289,000	$346,643,000	$95.74	1,561
2016 Q1	893,044,162	$92,609,940,962	-$2,342,978,344	$229,864,000	$353,561,000	$103.73	1,545
2015 Q4	918,665,396	$89,872,788,969	-$1,169,382,817	$446,871,000	$510,650,700	$97.77	1,546
2015 Q3	930,649,306	$89,772,711,977	+$452,661,446	$459,619,000	$393,326,800	$96.48	1,495
2015 Q2	932,490,480	$97,801,341,585	-$527,179,116	$325,531,000	$387,524,000	$104.88	1,474
2015 Q1	938,923,116	$96,891,534,061	-$2,012,979,554	$264,383,000	$362,167,000	$103.21	1,445
2014 Q4	959,101,291	$92,389,718,105	-$1,177,070,671	$381,150,000	$340,160,000	$96.31	1,405
2014 Q3	967,787,030	$77,023,824,218	-$334,904,756	$230,981,597	$216,153,000	$79.59	1,279
2014 Q2	967,892,104	$72,951,405,364	-$1,478,437,398	$152,373,000	$229,101,000	$75.37	1,257
2014 Q1	988,119,670	$73,935,267,317	-$591,640,692	$197,388,000	$220,888,000	$74.86	1,222